nadp has been researched along with Lymphangiomyomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blenis, J; Gerbaudo, VH; Gu, X; Henske, EP; Li, C; Morrison, T; Park, MA; Pereira, AM; Sun, Y; Wang, S; Yu, JJ; Zhang, E | 1 |
1 other study(ies) available for nadp and Lymphangiomyomatosis
| Article | Year |
|---|---|
Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Implants; Enzyme Activation; Estradiol; Female; Gene Expression Profiling; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucosephosphate Dehydrogenase; Humans; Lymphangioleiomyomatosis; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Mice, SCID; Multiprotein Complexes; NADP; Oxidative Stress; Pentose Phosphate Pathway; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2014 |